Position in LLY
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$73,454,298
+$16,377,051 QoQ
Shares Held
61,241
-1.3% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.80%
of 13F equity value
Holder Rank
#450
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$119,943
PutShares
100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Beacon Pointe Advisors, LLC holds $381,609,244 across 14 Drug Manufacturers - General names. LLY ranks #2 (19.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
365,648 | $92,863,622 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
61,241 | $73,454,298 | |
| 3 | ABBV |
AbbVie Inc.
|
195,761 | $49,261,298 | |
| 4 | MRK |
Merck & Co., Inc.
|
363,066 | $46,653,981 | |
| 5 | AMGN |
Amgen Inc
|
108,053 | $39,128,152 | |
| 6 | PFE |
Pfizer Inc
|
1,161,607 | $27,971,496 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
232,697 | $13,408,001 | |
| 8 | NVS |
Novartis AG
|
84,234 | $13,201,152 |
All Filings in LLY
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $73,454,298 | 61,241 | Shares | Sole | 2026-08-18 | |
| 2026-06-30 | $119,943 | 100 | Put | Sole | 2026-08-18 | |
| 2026-03-31 | $57,077,247 | 62,056 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $275,931 | 300 | Put | Sole | 2026-05-15 | |
| 2025-12-31 | $429,872 | 400 | Put | Sole | 2026-02-18 | |
| 2025-12-31 | $48,497,088 | 45,127 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $33,429,319 | 43,813 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $35,256,582 | 45,228 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $65,593,772 | 79,420 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $53,976,696 | 69,918 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $51,015,968 | 57,584 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $45,561,437 | 50,323 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $34,389,721 | 44,205 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $38,537,424 | 66,111 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $35,439,300 | 65,979 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $25,251,290 | 53,843 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $24,332,337 | 70,853 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $14,723,596 | 40,246 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $9,616,429 | 29,740 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $9,645,842 | 29,750 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $8,286,115 | 28,935 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $5,418,883 | 19,618 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,730,055 | 20,472 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,854,999 | 12,439 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $1,410,677 | 7,551 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $1,364,227 | 8,080 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $990,697 | 6,693 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,200,976 | 7,315 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $861,866 | 6,213 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||